Ушбу иш иқтибос қилган ишлар

90 та иш

Иш: Next-generation CAR-T and CAR-NK cell therapies in hematologic malignancies: engineering for persistence, specificity, and safety

Unveiling the potential of CLL-1: a promising target for AML therapy
Hamed Soleimani Samarkhazan, Sara Zehtabcheh, Hamideh Rahmani Seraji +4
Шарҳ мақола20256 иқтибос
ABI
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence
Beatrice Aramini, Valentina Masciale, Giulia Grisendi +8
Шарҳ мақола20226 иқтибос
ABI
Targeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions
Kaveh Hadiloo, Parsa Mostanadi, Ali Asadzadeh +2
Шарҳ мақола20256 иқтибос
ABI
Targeting cancer stem cell pathways for cancer therapy
Liqun Yang, Pengfei Shi, Gaichao Zhao +8
Шарҳ мақола20205 иқтибос
ABI
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
Xinyi Xiao, Shengkang Huang, Sifei Chen +4
Шарҳ мақола20215 иқтибос
ABI
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang +2
Шарҳ мақола20245 иқтибос
ABI
The clinical landscape of CAR NK cells
Lasse Vedel Jørgensen, Emil Birch Christensen, Mike Bogetofte Barnkob +1
Шарҳ мақола20255 иқтибос
ABI
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem, Jorge Mansilla‐Soto, Theodoros Giavridis +6
Мақола20174 иқтибос
ABI
CAR-T Cell Performance: How to Improve Their Persistence?
Gina López-Cantillo, Claudia Urueña, Bernardo Camacho +1
Шарҳ мақола20224 иқтибос
ABI
The tumor microenvironment’s role in the response to immune checkpoint blockade
Konstantinos Aliazis, Anthos Christofides, Rushil Shah +4
Шарҳ мақола20254 иқтибос
ABI
Cancer Stem Cell Plasticity – A Deadly Deal
Archana P. Thankamony, Kritika Saxena, Reshma Murali +2
Шарҳ мақола20204 иқтибос
ABI
Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
Yin Wang, Yan Liu, Sami N. Malek +2
Мақола20113 иқтибос
ABI
Engineering and Design of Chimeric Antigen Receptors
Sònia Guedan, Hugo Calderón, Avery D. Posey +1
Шарҳ мақола20183 иқтибос
ABI
Single-cell-guided identification of logic-gated antigen combinations for designing effective and safe CAR therapy
Sanna Madan, Tiangen Chang, Alexandra R. Harris +15
Препринт20253 иқтибос
ABI
Cancer stem cells (CSCs) in cancer progression and therapy
Masoud Najafi, Bagher Farhood, Keywan Mortezaee
Шарҳ мақола20183 иқтибос
ABI
CAR-T cell combination therapy: the next revolution in cancer treatment
Maysoon Al‐Haideri, Santalia Banne Tondok, Salar Hozhabri Safa +8
Шарҳ мақолаCAR-T cell therapy researchCancer Cell International20222 иқтибос
ABI
In vivo CAR T cell generation to treat cancer and autoimmune disease
Theresa Hunter, Yanjie Bao, Yan Zhang +37
Мақола20252 иқтибос
ABI
Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells
Esther Drent, Renée Poels, Ruud Ruiter +9
Мақола20192 иқтибос
ABI
Therapies targeting cancer stem cells: Current trends and future challenges
Denisa Dragu
Мақола20152 иқтибос
ABI
Targeting the tumour stroma to improve cancer therapy
Kenneth C. Valkenburg, Amber E. de Groot, Kenneth J. Pienta
Шарҳ мақола20182 иқтибос
ABI
Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications
Shunyao Zhu, Ziyi Luo, Xixi Li +3
Шарҳ мақола20202 иқтибос
ABI
Biomarkers of Cancer Stem Cells for Experimental Research and Clinical Application
Shigeo Saito, Chia‐Chen Ku, Kenly Wuputra +5
Шарҳ мақола20222 иқтибос
ABI
m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer
Belinda J. Petri, Carolyn M. Klinge
Шарҳ мақола20222 иқтибос
ABI
M6A Demethylase ALKBH5 in Human Diseases: From Structure to Mechanisms
Miaochun Fang, Liwen Ye, Yue Zhu +2
Шарҳ мақола20252 иқтибос
ABI
CAR-T Cell Therapy: the Efficacy and Toxicity Balance
Karan Chohan, Elizabeth L. Siegler, Saad S. Kenderian
Шарҳ мақола20232 иқтибос
ABI